Molecular BiologyJournal of Biological ChemistryPeer-reviewed
Ganaxolone, an approved therapy for CDKL5-Deficiency Disorder, is an inhibitor of PTP1B
Imanol Zubiete‐Franco, Qingting Hu, Steven R. Alves…·Nicholas K. Tonks
This study shows that Ganaxolone inhibits PTP1B, restores TRKB/BDNF signaling, and rescues cellular morphology in CDKL5-deficient cells.
1 citation